Skip to search.
 TSX Up 0.51% TSX Ventures Up 1.80%

Incyte Corporation (INCY)

-NasdaqGS
70.69 Up 0.28(0.40%) 4:00PM EDT
|After Hours : 70.69 0.00 (0.00%) 4:15PM EDT
Prev Close:70.41
Open:69.77
Bid:70.65 x 100
Ask:74.99 x 400
1y Target Est:91.64
Beta:0.5598
Next Earnings Date: 9-May-16INCY Earnings announcement
Day's Range:68.60 - 72.38
52wk Range:55.00 - 133.62
Volume:1,459,834
Avg Vol (3m):1,886,190
Market Cap:13.25B
P/E (ttm):2,356.33
EPS (ttm):0.03
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
INCYUp 0.40%13.25B
CELGDown 1.44%77.65B
AMGNDown 0.69%115.05B

Key Statistics

Forward P/E (1 yr):54.38
P/S (ttm):17.49
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :0.19
Quarterly EPS Est (Mar-16) :0.20
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):3.67

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Incyte Corporation focuses on the discovery, development, and commercialization of proprietary therapeutics in oncology. It offers JAKAFI for the treatment of myelofibrosis and polycythemia vera cancers. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback